StockWatch
·
Pharmaceuticals
Partnership17 Nov 2026, 02:03 pm

AstraZeneca Pharma India Signs LOI with Strand Life Sciences

AI Summary

AstraZeneca Pharma India Limited has signed a Letter of Intent (LOI) with Strand Life Sciences Private Limited, a subsidiary of Reliance Industries Limited. This collaboration aims to explore opportunities in healthcare within India. Both companies are not related parties, and the LOI execution does not constitute a related party transaction. Further communication regarding this development is available on AstraZeneca India's LinkedIn handle and the company's website.

Key Highlights

  • AstraZeneca India inks LOI with Strand Life Sciences.
  • Collaboration to explore healthcare opportunities in India.
  • No related party transaction involved.
  • Details shared on LinkedIn and company website.